动脉样硬化中的乌比基特异蛋白酶:探索超越传统方法的新疗法策略
Yumna Khan1, Rabab Fatima2, Baby Ilma3
1Institute of Biotechnology and Genetic Engineering (Health Division), The University of Agriculture, Peshawar 25000, Khyber Pakhtunkhwa, Pakistan.
European journal of pharmacology
|February 26, 2026
概括
乌比基特异蛋白酶 (USPs) 在动脉样硬化 (AS) 的发展中起着复杂的作用. 针对USP提供治疗潜力,但需要精确的,组织特异性的方法才能在治疗心血管疾病方面获得临床成功.
科学领域:
- 生物化学和分子生物学
- 心血管研究研究心血管研究
- 药物发现 药物发现 药物发现
背景情况:
- 动脉样硬化 (AS) 是心血管疾病的全球主要原因,需要新的治疗策略.
- 乌比基特异性蛋白酶 (USPs) 越来越多地被认为在AS病变发生过程中的关键作用.
- USP影响细胞过程,如脂质代谢,炎症和信号传递,影响AS的进展.
研究的目的:
- 审查USP在动脉样硬化中的双重和特定背景角色.
- 要突出治疗潜力和挑战的目标USPsAS治疗.
- 强调对USP向治疗的准确性医疗方法的需要.
主要方法:
- 对AS中USP功能研究的文献综述.
- 分析USP在与AS相关的细胞过程中的作用 (例如,脂质代谢,炎症).
- 检查针对USP的当前和新兴治疗策略.
主要成果:
- USP表现出上下文依赖的效应,其中一些促进AS (例如,USP14,USP20) 和其他潜在的保护性.
- 像USP9X这样的特定USP会影响泡细胞形成和斑块稳定性.
- 治疗方法包括小分子抑制剂,基因编辑和纳米技术.
结论:
- 关于AS中的组织和细胞特异性USP功能存在显著的知识差距.
- 准确的,USP的组织选择性调制对于临床翻译至关重要.
- 未来的研究应该专注于精准医学策略,以有效的USP向AS疗法.
相关概念视频
Atherosclerosis III: Management
516
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
516
Atherosclerosis I: Introduction
1.6K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.6K
Peripheral Artery Disease III: Interprofessional Care
433
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
433
Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
649
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
649
Atherosclerosis IV: Nursing Management
531
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
531


